Alessandro Bazzacco
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Discovery of a tetrahydrobenzothiophen-2-yl-pyrazolo[1,5-a]pyrimidine-3-carboxamide-based PROTAC as degrader of SARS-CoV-2 main protease.
Journal: European journal of medicinal chemistry
Published: December 30, 2025
New dengue virus inhibitors targeting NS3-NS5 interaction identified by in silico screening.
Journal: Frontiers in microbiology
Published: July 10, 2025
PROteolysis TArgeting Chimeras (PROTACs) and beyond: targeted degradation as a new path to fight microbial pathogens.
Journal: FEMS microbiology reviews
Published: April 17, 2025
Novel SARS-CoV-2 allosteric inhibitors that destabilize the Main Protease Mpro dimer.
Journal: International journal of biological macromolecules
Published: February 27, 2025
Design, synthesis, and biological evaluation of first-in-class indomethacin-based PROTACs degrading SARS-CoV-2 main protease and with broad-spectrum antiviral activity.
Journal: European journal of medicinal chemistry
Published: November 15, 2023
Indomethacin-based PROTACs as pan-coronavirus antiviral agents.
Journal: European journal of medicinal chemistry
Published: May 26, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026